Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George N Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, Eleni Karakike, Maria Saridaki, Georgia Loli, Aggelos Stefos, Danai Prasianaki, Sarah Georgiadou, Olga Tsachouridou, Vasileios Petrakis, Konstantinos Tsiakos, Maria Kosmidou, Vassiliki Lygoura, Maria Dareioti, Haralampos Milionis, Ilias C Papanikolaou, Karolina Akinosoglou, Dimitra-Melia Myrodia, Areti Gravvani, Aliki Stamou, Theologia Gkavogianni, Konstantina Katrini, Theodoros Marantos, Ioannis P Trontzas, Konstantinos Syrigos, Loukas Chatzis, Stamatios Chatzis, Nikolaos Vechlidis, Christina Avgoustou, Stamatios Chalvatzis, Miltiades Kyprianou, Jos Wm van der Meer, Jesper Eugen-Olsen, Mihai G Netea, Evangelos J. Giamarellos-Bourboulis
eLife 2021 Mar 8;10:e66125
DOI 10.7554/eLife.66125
Funding
Hellenic Institute for the Study of Sepsis, Technomar Shipping Inc, Swedish Orphan Biovitrum, Horizon 2020 Framework Programme (Grant reference number RISKinCOVID). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Keywords: COVID-19; SARS-CoV-2; anakinra; human; immunology; inflammation; interleukin-10; medicine; severe respiratory failure; suPAR
Related Studies: SAVE